Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hexaminolevulinate hydrochloride (P-1206) has approved for cystoscopic detection of papillary bladder cancer and it also is a fluorescent agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 47.00 | |
500 mg | In stock | $ 64.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Hexaminolevulinate hydrochloride (P-1206) has approved for cystoscopic detection of papillary bladder cancer and it also is a fluorescent agent. |
Synonyms | Hexyl 5-aminolevulinate hydrochloride, 5-Aminolevulinic acid hexyl ester hydrochloride, P-1206 |
Molecular Weight | 251.75 |
Formula | C11H22ClNO3 |
CAS No. | 140898-91-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 41 mg/mL (162.86 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hexaminolevulinate hydrochloride 140898-91-5 Others 5-Aminolevulinic acid hexyl ester inhibit 5-Aminolevulinic acid hexyl ester Hydrochloride Hexyl 5-aminolevulinate bladder cancer Hexyl 5-aminolevulinate hydrochloride P 1206 5-Aminolevulinic acid hexyl ester hydrochloride Hexyl 5-aminolevulinate Hydrochloride Inhibitor Hexaminolevulinate Hydrochloride Hexaminolevulinate P-1206 P1206 inhibitor